Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion type Assertion NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_head.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion description "[Since transgenic overexpression of Fra-2 causes not only fibrosis but also vascular disease, Fra-2 might be an interesting novel candidate for molecular-targeted therapies for SSc.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_provenance.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion evidence source_evidence_literature NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_provenance.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion SIO_000772 20039427 NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_provenance.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion wasDerivedFrom befree-20150227 NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_provenance.
- NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_assertion wasGeneratedBy ECO_0000203 NP411210.RAHWZmOf_73pDWwWS5TMzf-nlFluMXEQnfvt0vsRHPSLA130_provenance.